High-Dose antifungal shows promise against deadly fungus
NCT ID NCT00467883
First seen Mar 07, 2026 · Last updated Apr 29, 2026 · Updated 9 times
Summary
This study tested a high dose (10 mg/kg/day) of the antifungal drug Ambisome in 40 people with zygomycosis, a rare but serious fungal infection. The goal was to see if the treatment could control the infection, measured by complete or partial response after 4 weeks. Researchers also tracked side effects and survival at 15 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ZYGOMYCOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Necker - Service des Maladies Infectieuses et Tropicales
Paris, 75015, France
-
Necker Hospital
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.